Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Research

Analytical estimation of maximum fraction of infected individuals with one-shot non-pharmaceutical intervention in a hybrid epidemic model

Authors: Naoya Fujiwara, Tomokatsu Onaga, Takayuki Wada, Shouhei Takeuchi, Junji Seto, Tomoki Nakaya, Kazuyuki Aihara

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Facing a global epidemic of new infectious diseases such as COVID-19, non-pharmaceutical interventions (NPIs), which reduce transmission rates without medical actions, are being implemented around the world to mitigate spreads. One of the problems in assessing the effects of NPIs is that different NPIs have been implemented at different times based on the situation of each country; therefore, few assumptions can be shared about how the introduction of policies affects the patient population. Mathematical models can contribute to further understanding these phenomena by obtaining analytical solutions as well as numerical simulations.

Methods and results

In this study, an NPI was introduced into the SIR model for a conceptual study of infectious diseases under the condition that the transmission rate was reduced to a fixed value only once within a finite time duration, and its effect was analyzed numerically and theoretically. It was analytically shown that the maximum fraction of infected individuals and the final size could be larger if the intervention starts too early. The analytical results also suggested that more individuals may be infected at the peak of the second wave with a stronger intervention.

Conclusions

This study provides quantitative relationship between the strength of a one-shot intervention and the reduction in the number of patients with no approximation. This suggests the importance of the strength and time of NPIs, although detailed studies are necessary for the implementation of NPIs in complicated real-world environments as the model used in this study is based on various simplifications.
Appendix
Available only for authorised users
Literature
1.
go back to reference Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7(1):208.CrossRef Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7(1):208.CrossRef
2.
go back to reference Cohen J, Kupferschmidt K. Countries test tactics in war against COVID-19. Science. 2020;367(6484):1287–8.CrossRef Cohen J, Kupferschmidt K. Countries test tactics in war against COVID-19. Science. 2020;367(6484):1287–8.CrossRef
3.
go back to reference Flaxman S, Mishra S, Gandy A, Unwin H, Coupland H, Mellan T, Zhu H, Berah T, Eaton J, Perez Guzman P, et al. Report 13: estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries 2020. https://doi.org/10.25561/77731. Accessed 1 Mar 2021. Flaxman S, Mishra S, Gandy A, Unwin H, Coupland H, Mellan T, Zhu H, Berah T, Eaton J, Perez Guzman P, et al. Report 13: estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries 2020. https://​doi.​org/​10.​25561/​77731. Accessed 1 Mar 2021.
4.
go back to reference Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore y Piontti A, Mu K, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM, Vespignani A. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400.CrossRef Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore y Piontti A, Mu K, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM, Vespignani A. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400.CrossRef
5.
go back to reference Kraemer MU, Yang C-H, Gutierrez B, Wu C-H, Klein B, Pigott DM, Du Plessis L, Faria NR, Li R, Hanage WP, et al. The effect of human mobility and control measures on the COVID-19 epidemic in china. Science. 2020;368(6490):493–7.CrossRef Kraemer MU, Yang C-H, Gutierrez B, Wu C-H, Klein B, Pigott DM, Du Plessis L, Faria NR, Li R, Hanage WP, et al. The effect of human mobility and control measures on the COVID-19 epidemic in china. Science. 2020;368(6490):493–7.CrossRef
6.
go back to reference Kermack WO, McKendrick AG. A contribution to the mathematical theory of epidemics. Proc R Soc Lond. 1927;115(772):700–21. Kermack WO, McKendrick AG. A contribution to the mathematical theory of epidemics. Proc R Soc Lond. 1927;115(772):700–21.
7.
go back to reference Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1992. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1992.
8.
go back to reference Chowell G, Brauer F. The basic reproduction number of infectious diseases: computation and estimation using compartmental epidemic models. In: Mathematical and Statistical Estimation Approaches in Epidemiology, pp. 1–30. Springer, Dordrecht 2009. Chowell G, Brauer F. The basic reproduction number of infectious diseases: computation and estimation using compartmental epidemic models. In: Mathematical and Statistical Estimation Approaches in Epidemiology, pp. 1–30. Springer, Dordrecht 2009.
9.
go back to reference Inaba H. Age-structured population dynamics in demography and epidemiology. Singapore: Springer; 2017.CrossRef Inaba H. Age-structured population dynamics in demography and epidemiology. Singapore: Springer; 2017.CrossRef
10.
go back to reference Funk S, Salathé M, Jansen VAA. Modelling the influence of human behaviour on the spread of infectious diseases: a review. J R Soc Interface. 2010;7(50):1247–56.CrossRef Funk S, Salathé M, Jansen VAA. Modelling the influence of human behaviour on the spread of infectious diseases: a review. J R Soc Interface. 2010;7(50):1247–56.CrossRef
11.
go back to reference Merler S, Ajelli M, Pugliese A, Ferguson NM. Determinants of the spatiotemporal dynamics of the 2009 h1n1 pandemic in Europe: implications for real-time modelling. PLOS Comput Biol. 2011;7(9):1–13.CrossRef Merler S, Ajelli M, Pugliese A, Ferguson NM. Determinants of the spatiotemporal dynamics of the 2009 h1n1 pandemic in Europe: implications for real-time modelling. PLOS Comput Biol. 2011;7(9):1–13.CrossRef
12.
go back to reference He D, Dushoff J, Day T, Ma J, Earn DJ. Inferring the causes of the three waves of the 1918 influenza pandemic in england and wales. Proc R Soc B Biol Sci. 2013;280(1766):20131345.CrossRef He D, Dushoff J, Day T, Ma J, Earn DJ. Inferring the causes of the three waves of the 1918 influenza pandemic in england and wales. Proc R Soc B Biol Sci. 2013;280(1766):20131345.CrossRef
13.
go back to reference Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLOS Med. 2005;2(8):320.CrossRef Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLOS Med. 2005;2(8):320.CrossRef
14.
go back to reference Lin F, Muthuraman K, Lawley M. An optimal control theory approach to non-pharmaceutical interventions. BMC Infect Dis. 2010;10(1):32.CrossRef Lin F, Muthuraman K, Lawley M. An optimal control theory approach to non-pharmaceutical interventions. BMC Infect Dis. 2010;10(1):32.CrossRef
15.
go back to reference Perrings, C., Castillo-Chavez, C., Chowell, G., Daszak, P., Fenichel, E.P., Finnoff, D., Horan, R.D., Kilpatrick, A.M., Kinzig, A.P., Kuminoff, N.V., et al.: Merging economics and epidemiology to improve the prediction and management of infectious disease. EcoHealth 11(4), 464–475 (2014).CrossRef Perrings, C., Castillo-Chavez, C., Chowell, G., Daszak, P., Fenichel, E.P., Finnoff, D., Horan, R.D., Kilpatrick, A.M., Kinzig, A.P., Kuminoff, N.V., et al.: Merging economics and epidemiology to improve the prediction and management of infectious disease. EcoHealth 11(4), 464–475 (2014).CrossRef
16.
go back to reference Zhou Y, Yang K, Zhou K, Liang Y. Optimal vaccination policies for an sir model with limited resources. Acta Biotheor. 2014;62(2):171–81.CrossRef Zhou Y, Yang K, Zhou K, Liang Y. Optimal vaccination policies for an sir model with limited resources. Acta Biotheor. 2014;62(2):171–81.CrossRef
17.
go back to reference Ketcheson DI. Optimal control of an sir epidemic through finite-time non-pharmaceutical intervention. 2020. arXiv preprint arXiv:2004.08848. Accessed 1 Mar 2021. Ketcheson DI. Optimal control of an sir epidemic through finite-time non-pharmaceutical intervention. 2020. arXiv preprint arXiv:​2004.​08848. Accessed 1 Mar 2021.
18.
go back to reference Filippov AF. Differential equations with discontinuous righthand sides: control systems. Dordrecht: Kluwer; 1988.CrossRef Filippov AF. Differential equations with discontinuous righthand sides: control systems. Dordrecht: Kluwer; 1988.CrossRef
19.
go back to reference Lunze J, Lamnabhi-Lagarrigue F. Handbook of hybrid systems control: theory, tools, applications. Cambridge: Cambridge University Press; 2009.CrossRef Lunze J, Lamnabhi-Lagarrigue F. Handbook of hybrid systems control: theory, tools, applications. Cambridge: Cambridge University Press; 2009.CrossRef
20.
go back to reference Aihara K, Suzuki H. Theory of hybrid dynamical systems and its applications to biological and medical systems. Philos Trans A Math Phys Eng Sci. 2010;368(1930):4893–914.PubMed Aihara K, Suzuki H. Theory of hybrid dynamical systems and its applications to biological and medical systems. Philos Trans A Math Phys Eng Sci. 2010;368(1930):4893–914.PubMed
21.
go back to reference di Bernardo M, Hogan SJ. Discontinuity-induced bifurcations of piecewise smooth dynamical systems. Philos Trans A Math Phys Eng Sci. 2010;368(1930):4915–35.PubMed di Bernardo M, Hogan SJ. Discontinuity-induced bifurcations of piecewise smooth dynamical systems. Philos Trans A Math Phys Eng Sci. 2010;368(1930):4915–35.PubMed
22.
go back to reference Heemels WPMH, De Schutter B, Lunze J, Lazar M. Stability analysis and controller synthesis for hybrid dynamical systems. Philos Trans A Math Phys Eng Sci. 2010;368(1930):4937–60.PubMed Heemels WPMH, De Schutter B, Lunze J, Lazar M. Stability analysis and controller synthesis for hybrid dynamical systems. Philos Trans A Math Phys Eng Sci. 2010;368(1930):4937–60.PubMed
23.
go back to reference Agur Z, Cojocaru L, Mazor G, Anderson RM, Danon YL. Pulse mass measles vaccination across age cohorts. Proc Natl Acad Sci. 1993;90(24):11698–702.CrossRef Agur Z, Cojocaru L, Mazor G, Anderson RM, Danon YL. Pulse mass measles vaccination across age cohorts. Proc Natl Acad Sci. 1993;90(24):11698–702.CrossRef
24.
go back to reference Wang A, Xiao Y, Cheke RA. Global dynamics of a piece-wise epidemic model with switching vaccination strategy. DCDS-B. 2014;19(9):2915–40.CrossRef Wang A, Xiao Y, Cheke RA. Global dynamics of a piece-wise epidemic model with switching vaccination strategy. DCDS-B. 2014;19(9):2915–40.CrossRef
25.
go back to reference Chladná Z, Kopfová J, Rachinskii D, Rouf SC. Global dynamics of sir model with switched transmission rate. J Math Biol. 2020;80(4):1209–33.CrossRef Chladná Z, Kopfová J, Rachinskii D, Rouf SC. Global dynamics of sir model with switched transmission rate. J Math Biol. 2020;80(4):1209–33.CrossRef
26.
go back to reference Bootsma MC, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in us cities. Proc Natl Acad Sci. 2007;104(18):7588–93.CrossRef Bootsma MC, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in us cities. Proc Natl Acad Sci. 2007;104(18):7588–93.CrossRef
27.
go back to reference Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931–4.CrossRef Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931–4.CrossRef
28.
go back to reference Di Lauro F, Kiss IZ, Miller JC. Optimal timing of one-shot interventions for epidemic control. PLOS Comput Biol. 2021;17(3):1–25.CrossRef Di Lauro F, Kiss IZ, Miller JC. Optimal timing of one-shot interventions for epidemic control. PLOS Comput Biol. 2021;17(3):1–25.CrossRef
29.
go back to reference Morris DH, Rossine FW, Plotkin JB, Levin SA. Optimal, near-optimal, and robust epidemic control. 2020. arXiv:2004.02209. Accessed 1 Mar 2021. Morris DH, Rossine FW, Plotkin JB, Levin SA. Optimal, near-optimal, and robust epidemic control. 2020. arXiv:​2004.​02209. Accessed 1 Mar 2021.
32.
go back to reference Fujiwara N, Onaga T, Wada T, Aihara K. Effects of infection control policies on the final size. Seisan Kenkyu. 2020;72(2):141–3 (in Japanese). Fujiwara N, Onaga T, Wada T, Aihara K. Effects of infection control policies on the final size. Seisan Kenkyu. 2020;72(2):141–3 (in Japanese).
33.
go back to reference Liu Q-H, Ajelli M, Aleta A, Merler S, Moreno Y, Vespignani A. Measurability of the epidemic reproduction number in data-driven contact networks. Proc Natl Acad Sci. 2018;115(50):12680–5.CrossRef Liu Q-H, Ajelli M, Aleta A, Merler S, Moreno Y, Vespignani A. Measurability of the epidemic reproduction number in data-driven contact networks. Proc Natl Acad Sci. 2018;115(50):12680–5.CrossRef
34.
go back to reference Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, Bhatia S, Boonyasiri A, Cucunuba Perez Z, Cuomo-Dannenburg G, et al. Report 9: impact of non-pharmaceutical interventions (NPIS) to reduce covid19 mortality and healthcare demand 2020. https://doi.org/10.25561/77482. Accessed 1 Mar 2021. Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, Bhatia S, Boonyasiri A, Cucunuba Perez Z, Cuomo-Dannenburg G, et al. Report 9: impact of non-pharmaceutical interventions (NPIS) to reduce covid19 mortality and healthcare demand 2020. https://​doi.​org/​10.​25561/​77482. Accessed 1 Mar 2021.
35.
go back to reference Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-COV-2 through the postpandemic period. Science. 2020;368(6493):860–8.CrossRef Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-COV-2 through the postpandemic period. Science. 2020;368(6493):860–8.CrossRef
36.
go back to reference Liu Q-H, Bento AI, Yang K, Zhang H, Yang X, Merler S, Vespignani A, Lv J, Yu H, Zhang W, et al. The COVID-19 outbreak in Sichuan, China: epidemiology and impact of interventions. PLoS Comput Biol. 2020;16(12):1008467.CrossRef Liu Q-H, Bento AI, Yang K, Zhang H, Yang X, Merler S, Vespignani A, Lv J, Yu H, Zhang W, et al. The COVID-19 outbreak in Sichuan, China: epidemiology and impact of interventions. PLoS Comput Biol. 2020;16(12):1008467.CrossRef
40.
go back to reference Xiao Y, Xu X, Tang S. Sliding mode control of outbreaks of emerging infectious diseases. Bull Math Biol. 2012;74(10):2403–22.CrossRef Xiao Y, Xu X, Tang S. Sliding mode control of outbreaks of emerging infectious diseases. Bull Math Biol. 2012;74(10):2403–22.CrossRef
41.
go back to reference Khalili Amirabadi R, Heydari A, Zarrabi M. Analysis and control of seir epedemic model via sliding mode control. Adv Model Optim. 2016;18(1):153–62. Khalili Amirabadi R, Heydari A, Zarrabi M. Analysis and control of seir epedemic model via sliding mode control. Adv Model Optim. 2016;18(1):153–62.
43.
go back to reference Yabe T, Tsubouchi K, Fujiwara N, Wada T, Sekimoto Y, Ukkusuri SV. Non-compulsory measures sufficiently reduced human mobility in japan during the COVID-19 epidemic. Sci Rep. 2020;10:18053.CrossRef Yabe T, Tsubouchi K, Fujiwara N, Wada T, Sekimoto Y, Ukkusuri SV. Non-compulsory measures sufficiently reduced human mobility in japan during the COVID-19 epidemic. Sci Rep. 2020;10:18053.CrossRef
Metadata
Title
Analytical estimation of maximum fraction of infected individuals with one-shot non-pharmaceutical intervention in a hybrid epidemic model
Authors
Naoya Fujiwara
Tomokatsu Onaga
Takayuki Wada
Shouhei Takeuchi
Junji Seto
Tomoki Nakaya
Kazuyuki Aihara
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07403-5

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.